<?xml version="1.0" encoding="UTF-8"?>
<p id="P47">Amantadine is generally well tolerated. Among its adverse effects are mild neurologic symptoms such as anxiety, disorientation, and headache, especially in elderly patients and those taking neuroaffective drugs. Emergence of amantadine resistance has limited its use in the clinical setting.
 <sup>
  <xref ref-type="bibr" rid="R94">94</xref>,
  <xref ref-type="bibr" rid="R95">95</xref>
 </sup> Amantadine resistance, characterized by amino acid substitutions in the M
 <sub>2</sub> protein, emerges within 2 to 4 days of treatment. Because of widespread resistance, amantadine is no longer recommended for empiric treatment of influenza.
 <sup>
  <xref ref-type="bibr" rid="R94">94</xref>,
  <xref ref-type="bibr" rid="R95">95</xref>
 </sup> M
 <sub>2</sub> mutation confers cross-resistance with rimantadine.
</p>
